mIgG2a anti-TIGIT, but not mIgG2b or Fc-inert anti-TIGIT, antibodies were capable of inducing tumour rejection when combined with Fc inert mouse anti-PD-L1 (Fig. 4a). The gene discussed is TIGIT; the disease is neoplasm.